Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 84 of 95, showing 5 Applications out of 474 total, starting on record 416, ending on 420

# Protocol No Study Title Investigator(s) & Site(s)

416.

ECCT/13/08/01   M72/AS01 E
    A phase IIb, double-blind, randomised, placebo-controlled study to evaluate the efficacy, safety and immunogenicity of GSK Biologicals’ candidatetuberculosis (TB) vaccine GSK 692342 against TB disease, in healthy adults aged 18-50 years, living  in a TB endemic region.   
Principal Investigator(s)
1. Dr Videlis Nduba
Site(s) in Kenya
KEMRI-CDC
 
View

417.

ECCT/13/07/05  
    Single Dose Escalating, Single-blind Phase 1 Trial in Healthy Male Volunteers to Evalute the Safety, Tolerability and the Pharmacokinetics of Oleylphosphocholine.   
Principal Investigator(s)
1. Rashid Ravasco Juma
Site(s) in Kenya
KEMRI Centre for Clinical Research
 
View

418.

ECCT/13/07/04   Advanced Kapsosis Sarcoma Chemotherapy Regimens
    A Randomized Comparison of Three Regimens of Chemotherapy with Compatible Antiretroviral Therapy for Treatment of Advanced AIDS-KS in Resource-Limited Settings   
Principal Investigator(s)
1. Josphat Kosgei
Site(s) in Kenya
1. WRP/KEMRI - Kericho (Kericho county)
2. AMPATH - MOI University Teaching Hospital Eldoret CRS (Uasin Gishu county)
 
View

419.

ECCT/13/07/03  
    Pharmacokinetic and pharmacodynamic studies of efficacy, tolerability and safety of higher dosage rifapentine for treatment of tuberculosis   
Principal Investigator(s)
1. Dr Lena Matata
Site(s) in Kenya
KEMRI-CDC
 
View

420.

ECCT/13/07/01   HIVCORE004/N004
    A phase I/IIa clinical trial of universal HIV-1 vaccines pSG2.HIVconsv DNA, MVA.HIVconsv and ChAdV63.HIVconsv in combined regimens in healthy HIV-1/2-negative adults in Nairobi.   
Principal Investigator(s)
1. Prof. Walter Godfrey Jaoko
Site(s) in Kenya
KAVI-KANGEMI RESEARCH SITE
 
View